FCSAnalysisCount <> 0
L02-060329-PV1-R1 analysis2008-11-17 19:48Matthew BellewPeptide ValidationAnalysisFlowAnalysisFlowScriptL02-060329-PV1-R1 comp matrix110
L02-060417-PV1-R1 analysis2008-11-17 18:53Matthew BellewPeptide ValidationAnalysisFlowAnalysisFlowScriptL02-060417-PV1-R1 comp matrix108
L02-060414-PV1-R1 analysis2008-11-17 18:02Matthew BellewPeptide ValidationAnalysisFlowAnalysisFlowScriptL02-060414-PV1-R1 comp matrix82
L02-060413-PV1-R1 analysis2008-11-17 17:14Matthew BellewPeptide ValidationAnalysisFlowAnalysisFlowScriptL02-060413-PV1-R1 comp matrix108
L02-060410-PV1-R1 analysis2008-11-17 16:21Matthew BellewPeptide ValidationAnalysisFlowAnalysisFlowScriptL02-060410-PV1-R1 comp matrix108
L02-060407-PV1-R1 analysis2008-11-17 15:25Matthew BellewPeptide ValidationAnalysisFlowAnalysisFlowScriptL02-060407-PV1-R1 comp matrix108
L02-060406-PV1-R1 analysis2008-11-17 14:31Matthew BellewPeptide ValidationAnalysisFlowAnalysisFlowScriptL02-060406-PV1-R1 comp matrix108
L02-060405-PV1-R1 analysis2008-11-17 13:38Matthew BellewPeptide ValidationAnalysisFlowAnalysisFlowScriptL02-060405-PV1-R1 comp matrix108
L02-060403-PV1-R1 analysis2008-11-17 12:46Matthew BellewPeptide ValidationAnalysisFlowAnalysisFlowScriptL02-060403-PV1-R1 comp matrix108
L02-060331-PV1-R1 analysis2008-11-17 11:48Matthew BellewPeptide ValidationAnalysisFlowAnalysisFlowScriptL02-060331-PV1-R1 comp matrix108
L02-060330-PV1-R1 analysis2008-11-17 10:54Matthew BellewPeptide ValidationAnalysisFlowAnalysisFlowScriptL02-060330-PV1-R1 comp matrix108